133 related articles for article (PubMed ID: 21251044)
1. RNA integrity in post mortem human variant Creutzfeldt-Jakob disease (vCJD) and control brain tissue.
Sherwood KR; Head MW; Walker R; Smith C; Ironside JW; Fazakerley JK
Neuropathol Appl Neurobiol; 2011 Oct; 37(6):633-42. PubMed ID: 21251044
[TBL] [Abstract][Full Text] [Related]
2. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002.
Head MW; Bunn TJ; Bishop MT; McLoughlin V; Lowrie S; McKimmie CS; Williams MC; McCardle L; MacKenzie J; Knight R; Will RG; Ironside JW
Ann Neurol; 2004 Jun; 55(6):851-9. PubMed ID: 15174020
[TBL] [Abstract][Full Text] [Related]
3. Pathological diagnosis of variant Creutzfeldt-Jakob disease.
Ironside JW; McCardle L; Horsburgh A; Lim Z; Head MW
APMIS; 2002 Jan; 110(1):79-87. PubMed ID: 12064259
[TBL] [Abstract][Full Text] [Related]
4. A case of MV2K subtype of sporadic Creutzfeldt-Jakob disease with florid-like plaques: Similarities and differences to variant Creutzfeldt-Jakob disease.
Bošnjak M; Zupan A; Fiorini M; Popović KŠ; Popović M
Neuropathology; 2020 Aug; 40(4):389-398. PubMed ID: 32249464
[TBL] [Abstract][Full Text] [Related]
5. Laboratory diagnosis of variant Creutzfeldt-Jakob disease.
Ironside JW; Head MW; Bell JE; McCardle L; Will RG
Histopathology; 2000 Jul; 37(1):1-9. PubMed ID: 10931212
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural study of florid plaques in variant Creutzfeldt-Jakob disease: a comparison with amyloid plaques in kuru, sporadic Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker disease.
Sikorska B; Liberski PP; Sobów T; Budka H; Ironside JW
Neuropathol Appl Neurobiol; 2009 Feb; 35(1):46-59. PubMed ID: 18513219
[TBL] [Abstract][Full Text] [Related]
7. Clinical, neuropathological and immunohistochemical features of sporadic and variant forms of Creutzfeldt-Jakob disease in the squirrel monkey (Saimiri sciureus).
Williams L; Brown P; Ironside J; Gibson S; Will R; Ritchie D; Kreil TR; Abee C
J Gen Virol; 2007 Feb; 88(Pt 2):688-695. PubMed ID: 17251588
[TBL] [Abstract][Full Text] [Related]
8. Study protocol for enhanced CJD surveillance in the 65+ years population group in Scotland: an observational neuropathological screening study of banked brain tissue donations for evidence of prion disease.
Peden AH; Kanguru L; Ritchie DL; Smith C; Molesworth AM
BMJ Open; 2019 Oct; 9(10):e033744. PubMed ID: 31662408
[TBL] [Abstract][Full Text] [Related]
9. Detection of infectivity in blood of persons with variant and sporadic Creutzfeldt-Jakob disease.
Douet JY; Zafar S; Perret-Liaudet A; Lacroux C; Lugan S; Aron N; Cassard H; Ponto C; Corbière F; Torres JM; Zerr I; Andreoletti O
Emerg Infect Dis; 2014 Jan; 20(1):114-7. PubMed ID: 24377668
[TBL] [Abstract][Full Text] [Related]
10. Red-backed vole brain promotes highly efficient in vitro amplification of abnormal prion protein from macaque and human brains infected with variant Creutzfeldt-Jakob disease agent.
Nemecek J; Nag N; Carlson CM; Schneider JR; Heisey DM; Johnson CJ; Asher DM; Gregori L
PLoS One; 2013; 8(10):e78710. PubMed ID: 24205298
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E and other cerebrospinal fluid proteins differentiate ante mortem variant Creutzfeldt-Jakob disease from ante mortem sporadic Creutzfeldt-Jakob disease.
Choe LH; Green A; Knight RS; Thompson EJ; Lee KH
Electrophoresis; 2002 Jul; 23(14):2242-6. PubMed ID: 12210228
[TBL] [Abstract][Full Text] [Related]
12. Autophagy is a part of ultrastructural synaptic pathology in Creutzfeldt-Jakob disease: a brain biopsy study.
Sikorska B; Liberski PP; Giraud P; Kopp N; Brown P
Int J Biochem Cell Biol; 2004 Dec; 36(12):2563-73. PubMed ID: 15325593
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report.
Wroe SJ; Pal S; Siddique D; Hyare H; Macfarlane R; Joiner S; Linehan JM; Brandner S; Wadsworth JD; Hewitt P; Collinge J
Lancet; 2006 Dec; 368(9552):2061-7. PubMed ID: 17161728
[TBL] [Abstract][Full Text] [Related]
14. Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease.
Bartoletti-Stella A; Corrado P; Mometto N; Baiardi S; Durrenberger PF; Arzberger T; Reynolds R; Kretzschmar H; Capellari S; Parchi P
Mol Neurobiol; 2019 Jul; 56(7):5009-5024. PubMed ID: 30446946
[TBL] [Abstract][Full Text] [Related]
15. Brains with sporadic Creutzfeldt-Jakob disease and copathology showed a prolonged end-stage of disease.
Miguelez-Rodriguez A; Santos-Juanes J; Vicente-Etxenausia I; Perez de Heredia-Goñi K; Garcia B; Quiros LM; Lorente-Gea L; Guerra-Merino I; Aguirre JJ; Fernandez-Vega I
J Clin Pathol; 2018 May; 71(5):446-450. PubMed ID: 29097599
[TBL] [Abstract][Full Text] [Related]
16. Creutzfeldt-Jakob disease: report of four cases and review of the literature.
Atalay FÖ; Tolunay Ş; Özgün G; Bekar A; Zarifoğlu M
Turk Patoloji Derg; 2015; 31(2):148-52. PubMed ID: 24272930
[TBL] [Abstract][Full Text] [Related]
17. Biopsy diagnosis of Creutzfeldt-Jakob disease by western blot: a case report.
Castellani RJ; Parchi P; Madoff L; Gambetti P; McKeever P
Hum Pathol; 1997 May; 28(5):623-6. PubMed ID: 9158712
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis of prion diseases].
Federspil PA; Federspil P; Plinkert PK
HNO; 2002 Apr; 50(4):327-31. PubMed ID: 12063690
[TBL] [Abstract][Full Text] [Related]
19. PMCA Applications for Prion Detection in Peripheral Tissues of Patients with Variant Creutzfeldt-Jakob Disease.
Giaccone G; Moda F
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32151109
[TBL] [Abstract][Full Text] [Related]
20. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay.
Wadsworth JD; Joiner S; Hill AF; Campbell TA; Desbruslais M; Luthert PJ; Collinge J
Lancet; 2001 Jul; 358(9277):171-80. PubMed ID: 11476832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
